Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 13Lung Neoplasms 2Esophageal Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sjogren's Syndrome 1Scleroderma, Systemic 1Retinoblastoma 1Resectable Stage II-III Non-Small Cell Lung Cancer (NSCLC) 1Resectable Non-small Cell Lung Cancer 1Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Psoriasis 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Multiple Sclerosis 1Lupus Erythematosus, Systemic 1Inflammatory Bowel Diseases 1Hematologic Neoplasms 1Dermatomyositis 1Crohn Disease 1Colitis, Ulcerative 1Carcinoma, Ovarian Epithelial 1Carcinoma, Bronchogenic 1Bronchial Neoplasms 1Autoimmune Diseases 1Arthritis, Rheumatoid 1Arthritis, Psoriatic 1Advanced Non-small Cell Lung Cancer 1

Interventions

pembrolizumab 2Carboplatin 2tislelizumab 1aumolertinib 1anlotinib 1aflutinib 1Platinum Compounds 1Pemetrexed 1Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Non-small Cell Lung Cancer × Platinum Compounds × Clear all
NCT05416775 2022-08-19

Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 1/2 Recruiting
168 enrolled
Thoracic

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡